| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1116.168 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1116.168/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 |
| Version | 20220910 |
| Status | active |
| Date | 2022-09-10T01:02:30-04:00 |
| Name | DoxorubicinInjectable |
| Title | Doxorubicin Injectable |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains concepts that represent the medication Doxorubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Doxorubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; doxorubicin pegylated liposomal.) |
| ValueSet | |
| 2.16.840.1.113883.3.1444.5.200 | Doxorubicin |
| 2.16.840.1.113883.3.1444.5.243 | Moderate Emetic Risk Intravenous Antineoplastic Agent |
| 2.16.840.1.113883.3.1444.5.244 | Anthracycline Injectable |
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR